Changes to the gut microbiome interacted with the immune system to slow the growth of cancer in mice exposed to cigarette smoke, according to research that was selected for presentation at Digestive Disease Week® (DDW) 2020.

Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumours.

A comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 genetic screens in 725 cancer models, across 25 different cancer types.

Researchers are exploring the use of experimental medication to prevent heart disease for chemo-resistant ovarian cancer

Researchers have identified a promising new drug combination that could significantly help the immune system target cancer cells and kill them.

A study by researchers at UT Southwestern Medical Center and the University of Chicago suggests that gut bacteria can penetrate tumour cells and boost the effectiveness of an experimental immunotherapy that targets the CD47 protein.